Projects
Publications
Download-
2016Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles., PLoS One 2016 ; 11(8): e0160251.
-
2015Rosuvastatin is effective to decrease CD8 T-cell activation only in HIV-infected patients with high residual T-cell activation under antiretroviral therapy, J. Acquir. Immune Defic. Syndr. 2015 Nov;.
-
2015A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control, AIDS 2015 Sep;29(15):2003-7.
-
2015Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates, PLoS ONE 2015;10(8):e0134904.
-
2015Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial, Lancet Infect Dis 2015 Jul;15(7):785-92.
-
2015Real-life long-term omalizumab therapy in children with severe allergic asthma, Eur. Respir. J. 2015 Sep;46(3):856-9.
-
2015Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR, N. Engl. J. Med. 2015 Jul;373(3):220-31.
-
2015Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?, BMC Infect. Dis. 2015;15:178.
-
2015Why START? Reflections that led to the conduct of this large long-term strategic HIV trial, HIV Med. 2015 Apr;16 Suppl 1:1-9.
-
2015Immediate T-Helper 17 Polarization Upon Triggering CD11b/c on HIV-Exposed Dendritic Cells, J. Infect. Dis. 2015 Jul;212(1):44-56.
-
+View full list of publications